MSD and Genentech Settle PTO Dispute Over Cabilly Patent

Merck Sharp & Dohme Corp. is settling its challenge over a Genentech patent on methods for artificially synthesizing antibodies, a process used for a variety of specialty medicines and cancer therapies.
Source: Drug Industry Daily